Thu, Dec 18, 2014, 5:19 AM EST - U.S. Markets open in 4 hrs 11 mins


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • jiafli jiafli Feb 22, 2013 11:42 AM Flag

    IMGN is going up from here...

    (1) IMGN earning report in April will reflect FDA approval milestone payment (2) In 2 weeks, Genentech will be aggressively marketing T-DM1= more royalty payment for IMGN. Most likely sales figures will blow past analysts predictions (3) EU approval is expected before year end (4) IMGN will have data to support T-DM1 for 1st line use= more revenue= more royalties. Now that T-DM1 is approved, IMGN will be on everyone's radar.

10.725+0.8950(+9.10%)Dec 17 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.